SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008739
Filing Date
2022-05-10
Accepted
2022-05-10 08:15:02
Documents
67
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ovid-20220331.htm   iXBRL 10-Q 2159554
2 EX-10.1 ovid-ex10_1.htm EX-10.1 25815
3 PDF COURTESY COPY ovid-ex10_1.pdf EX-10.1 125793
4 EX-31.1 ovid-ex31_1.htm EX-31.1 22019
5 EX-31.2 ovid-ex31_2.htm EX-31.2 22038
6 EX-32.1 ovid-ex32_1.htm EX-32.1 11295
7 GRAPHIC img42364362_0.gif GRAPHIC 157859
  Complete submission text file 0000950170-22-008739.txt   8037061

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovid-20220331_cal.xml EX-101.CAL 38446
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ovid-20220331_lab.xml EX-101.LAB 411568
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovid-20220331_pre.xml EX-101.PRE 294877
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovid-20220331.xsd EX-101.SCH 47986
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovid-20220331_def.xml EX-101.DEF 169685
61 EXTRACTED XBRL INSTANCE DOCUMENT ovid-20220331_htm.xml XML 1225353
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38085 | Film No.: 22907484
SIC: 2834 Pharmaceutical Preparations